BGM Group Ltd. SEC filings BGM
BGM Group Ltd. has 154 filings in SEC EDGAR's recent list, going back to Jun 17, 2019. Its latest annual report, Form 20-F, was filed on Jul 21, 2026 for the period ended Sep 30, 2025. The most recent current report (Form 6-K) was filed on Sep 24, 2026. The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Sep 24, 2026 | Sep 24, 2026 |
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Sep 8, 2026 |
| 6-K | Current report (foreign issuer) | Aug 28, 2026 | Aug 28, 2026 |
| 6-K | Current report (foreign issuer) | Aug 11, 2026 | Aug 11, 2026 |
| 6-K | Current report (foreign issuer) | Jul 30, 2026 | Jul 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 28, 2026 | Jul 28, 2026 |
| 20-F | Annual report (foreign issuer) | Jul 21, 2026 | Sep 30, 2025 |
| 6-K | Current report (foreign issuer) | Jul 13, 2026 | Jul 13, 2026 |
| 6-K | Current report (foreign issuer) | Jun 17, 2026 | Jun 17, 2026 |
| 6-K | Current report (foreign issuer) | Jun 9, 2026 | Jun 9, 2026 |
| 6-K | Current report (foreign issuer) | May 18, 2026 | May 18, 2026 |
| 3 | Initial insider ownership | May 14, 2026 | Mar 31, 2026 |
| 3 | Initial insider ownership | May 14, 2026 | Mar 31, 2026 |
| 3 | Initial insider ownership | May 14, 2026 | Mar 31, 2026 |
| 3 | Initial insider ownership | May 14, 2026 | Apr 28, 2026 |
| 6-K | Current report (foreign issuer) | May 7, 2026 | May 7, 2026 |
| 6-K | Current report (foreign issuer) | Apr 30, 2026 | Apr 30, 2026 |
| 3 | Initial insider ownership | Apr 13, 2026 | Apr 13, 2026 |
| NT 20-F | Filing | Jan 30, 2026 | Sep 30, 2025 |
| 6-K | Current report (foreign issuer) | Jan 29, 2026 | Jan 29, 2026 |
| 6-K | Current report (foreign issuer) | Dec 22, 2025 | Dec 18, 2025 |
| 6-K | Current report (foreign issuer) | Aug 14, 2025 | Aug 14, 2025 |
| 6-K | Current report (foreign issuer) | Jul 24, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Jun 26, 2025 | Jun 26, 2025 |
| S-8 | Employee stock plan registration | Jun 3, 2025 | — |
| 6-K | Current report (foreign issuer) | May 28, 2025 | May 28, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 28, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 28, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 27, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | May 27, 2025 | — |
| UPLOAD | Letter from the SEC | May 20, 2025 | — |
| 6-K | Current report (foreign issuer) | May 20, 2025 | May 20, 2025 |
| CORRESP | Letter to the SEC | May 8, 2025 | — |
| 20-F/A | Amended annual report (foreign issuer) | May 8, 2025 | Sep 30, 2024 |
| 6-K | Current report (foreign issuer) | May 6, 2025 | May 6, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 6, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 6, 2025 | — |
| 6-K | Current report (foreign issuer) | Apr 28, 2025 | Apr 28, 2025 |
| UPLOAD | Letter from the SEC | Apr 25, 2025 | — |
| 6-K | Current report (foreign issuer) | Apr 22, 2025 | Apr 22, 2025 |
| CORRESP | Letter to the SEC | Apr 3, 2025 | — |
| 20-F/A | Amended annual report (foreign issuer) | Apr 3, 2025 | Sep 30, 2024 |
| EFFECT | Filing | Apr 2, 2025 | — |
| CORRESP | Letter to the SEC | Mar 31, 2025 | — |
| 6-K | Current report (foreign issuer) | Mar 28, 2025 | Mar 28, 2025 |
| UPLOAD | Letter from the SEC | Mar 24, 2025 | — |
| 6-K | Current report (foreign issuer) | Mar 19, 2025 | Mar 19, 2025 |
| UPLOAD | Letter from the SEC | Mar 17, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 7, 2025 | — |
| 6-K | Current report (foreign issuer) | Feb 28, 2025 | Feb 28, 2025 |
| 20-F/A | Amended annual report (foreign issuer) | Feb 6, 2025 | Sep 30, 2024 |
| 20-F | Annual report (foreign issuer) | Jan 27, 2025 | Sep 30, 2024 |
| 6-K | Current report (foreign issuer) | Jan 7, 2025 | Jan 7, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Jan 6, 2025 | — |
| SC 13D | Ownership over 5% (active) | Dec 3, 2024 | — |
| 6-K | Current report (foreign issuer) | Nov 29, 2024 | Nov 29, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 29, 2024 | — |
| 6-K | Current report (foreign issuer) | Nov 27, 2024 | Nov 27, 2024 |
| EFFECT | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 22, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 5, 2024 | — |
| 6-K | Current report (foreign issuer) | Oct 22, 2024 | Oct 22, 2024 |
| SC 13D | Ownership over 5% (active) | Oct 16, 2024 | — |
| 6-K/A | Form 6-k/a | Oct 10, 2024 | Oct 10, 2024 |
| 6-K | Current report (foreign issuer) | Sep 9, 2024 | Sep 9, 2024 |
| 6-K | Current report (foreign issuer) | Aug 14, 2024 | Mar 31, 2024 |
| 6-K | Current report (foreign issuer) | Jun 6, 2024 | Jun 6, 2024 |
| 6-K | Current report (foreign issuer) | Jun 4, 2024 | Jun 3, 2024 |
| EFFECT | Filing | May 16, 2024 | — |
| CORRESP | Letter to the SEC | May 15, 2024 | — |
| CORRESP | Letter to the SEC | May 8, 2024 | — |
| F-3/A | Form f-3/a | May 8, 2024 | — |
| 6-K | Current report (foreign issuer) | Apr 25, 2024 | Apr 25, 2024 |
| UPLOAD | Letter from the SEC | Apr 18, 2024 | — |
| S-8 | Employee stock plan registration | Apr 10, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 10, 2024 | — |
| 6-K | Current report (foreign issuer) | Mar 11, 2024 | Mar 11, 2024 |
| 20-F | Annual report (foreign issuer) | Feb 15, 2024 | Sep 30, 2023 |
| NT 20-F | Filing | Feb 1, 2024 | Sep 30, 2023 |
| 6-K | Current report (foreign issuer) | Dec 20, 2023 | Dec 19, 2023 |
| 6-K | Current report (foreign issuer) | Dec 7, 2023 | Dec 7, 2023 |
| 6-K | Current report (foreign issuer) | Oct 31, 2023 | Oct 31, 2023 |
| 6-K | Current report (foreign issuer) | Aug 4, 2023 | Aug 4, 2023 |
| 6-K | Current report (foreign issuer) | Jul 25, 2023 | Jul 25, 2023 |
| 6-K | Current report (foreign issuer) | Jun 14, 2023 | Jun 14, 2023 |
| 6-K | Current report (foreign issuer) | Apr 26, 2023 | Apr 26, 2023 |
| 20-F | Annual report (foreign issuer) | Apr 19, 2023 | Sep 30, 2022 |
| 6-K | Current report (foreign issuer) | Feb 23, 2023 | Feb 23, 2023 |
| 6-K | Current report (foreign issuer) | Feb 16, 2023 | Feb 16, 2023 |
| NT 20-F | Filing | Jan 31, 2023 | Sep 30, 2022 |
| 6-K | Current report (foreign issuer) | Jan 10, 2023 | Jan 10, 2023 |
| 6-K | Current report (foreign issuer) | Dec 7, 2022 | Dec 7, 2022 |
| 6-K | Current report (foreign issuer) | Nov 17, 2022 | Nov 17, 2022 |
| UPLOAD | Letter from the SEC | Oct 28, 2022 | — |
| CORRESP | Letter to the SEC | Oct 13, 2022 | — |
| 20-F/A | Amended annual report (foreign issuer) | Oct 13, 2022 | Sep 30, 2021 |
| 6-K | Current report (foreign issuer) | Oct 4, 2022 | Oct 4, 2022 |
| 6-K | Current report (foreign issuer) | Sep 30, 2022 | Sep 30, 2022 |
| 6-K | Current report (foreign issuer) | Aug 29, 2022 | Aug 29, 2022 |
| UPLOAD | Letter from the SEC | Aug 19, 2022 | — |
| 20-F/A | Amended annual report (foreign issuer) | Aug 1, 2022 | Sep 30, 2021 |
| CORRESP | Letter to the SEC | Jul 29, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2022 | — |
| CORRESP | Letter to the SEC | Jun 30, 2022 | — |
| 20-F/A | Amended annual report (foreign issuer) | Jun 30, 2022 | Sep 30, 2021 |
| UPLOAD | Letter from the SEC | Apr 28, 2022 | — |
| 6-K | Current report (foreign issuer) | Apr 15, 2022 | Apr 15, 2022 |
| 6-K | Current report (foreign issuer) | Feb 11, 2022 | Feb 11, 2022 |
| 20-F | Annual report (foreign issuer) | Feb 11, 2022 | Sep 30, 2021 |
| NT 20-F | Form 12b-25 | Jan 31, 2022 | Sep 30, 2021 |
| 6-K | Current report (foreign issuer) | Sep 16, 2021 | Sep 9, 2021 |
| 20-F/A | Amended annual report (foreign issuer) | Mar 9, 2021 | Sep 30, 2020 |
| 6-K | Current report (foreign issuer) | Feb 11, 2021 | Feb 11, 2021 |
| 20-F | Annual report (foreign issuer) | Feb 11, 2021 | Sep 30, 2020 |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2021 | — |
| 6-K | Current report (foreign issuer) | Jan 20, 2021 | Jan 20, 2021 |
| 6-K | Current report (foreign issuer) | Jan 15, 2021 | Jan 15, 2021 |
| 424B4 | Prospectus | Jan 12, 2021 | — |
| CERT | Filing | Jan 11, 2021 | — |
| EFFECT | Filing | Dec 30, 2020 | — |
| CORRESP | Letter to the SEC | Dec 28, 2020 | — |
| CORRESP | Letter to the SEC | Dec 28, 2020 | — |
| F-1/A | Filing | Dec 23, 2020 | — |
| F-1/A | Filing | Dec 18, 2020 | — |
| 8-A12B | Filing | Dec 14, 2020 | — |
| F-1/A | Filing | Dec 10, 2020 | — |
| CORRESP | Letter to the SEC | Dec 10, 2020 | — |
| FWP | Free writing prospectus | Dec 9, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 8, 2020 | — |
| FWP | Free writing prospectus | Dec 8, 2020 | — |
| FWP | Free writing prospectus | Dec 8, 2020 | — |
| F-1/A | Filing | Nov 23, 2020 | — |
| F-1/A | Filing | Aug 21, 2020 | — |
| CORRESP | Letter to the SEC | Jun 12, 2020 | — |
| F-1/A | Filing | Jun 12, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2020 | — |
| F-1/A | Filing | Apr 8, 2020 | — |
| FWP | Free writing prospectus | Jan 21, 2020 | — |
| CORRESP | Letter to the SEC | Jan 2, 2020 | — |
| F-1/A | Filing | Jan 2, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 5, 2019 | — |
| CORRESP | Letter to the SEC | Nov 27, 2019 | — |
| F-1/A | Filing | Nov 27, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 12, 2019 | — |
| F-1 | Registration statement (foreign issuer) | Nov 4, 2019 | — |
| CORRESP | Letter to the SEC | Nov 1, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2019 | — |
| DRS/A | Filing | Sep 9, 2019 | — |
| DRSLTR | Filing | Sep 6, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2019 | — |
| DRS | Filing | Jun 17, 2019 | — |
Showing 154 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BGM (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- Cayman Islands
- Headquarters
- Chengdu
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1779578
- Former names
- Qilian International Holding Group (until Oct 22, 2024); Qilian International Holding Group Ltd (until Oct 16, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.